Correlation Between Dynavax Technologies and Brainstorm Cell
Can any of the company-specific risk be diversified away by investing in both Dynavax Technologies and Brainstorm Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dynavax Technologies and Brainstorm Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dynavax Technologies and Brainstorm Cell Therapeutics, you can compare the effects of market volatilities on Dynavax Technologies and Brainstorm Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dynavax Technologies with a short position of Brainstorm Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dynavax Technologies and Brainstorm Cell.
Diversification Opportunities for Dynavax Technologies and Brainstorm Cell
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Dynavax and Brainstorm is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Dynavax Technologies and Brainstorm Cell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brainstorm Cell Ther and Dynavax Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dynavax Technologies are associated (or correlated) with Brainstorm Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brainstorm Cell Ther has no effect on the direction of Dynavax Technologies i.e., Dynavax Technologies and Brainstorm Cell go up and down completely randomly.
Pair Corralation between Dynavax Technologies and Brainstorm Cell
Given the investment horizon of 90 days Dynavax Technologies is expected to under-perform the Brainstorm Cell. But the stock apears to be less risky and, when comparing its historical volatility, Dynavax Technologies is 4.27 times less risky than Brainstorm Cell. The stock trades about -0.01 of its potential returns per unit of risk. The Brainstorm Cell Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 245.00 in Brainstorm Cell Therapeutics on September 4, 2024 and sell it today you would lose (74.00) from holding Brainstorm Cell Therapeutics or give up 30.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dynavax Technologies vs. Brainstorm Cell Therapeutics
Performance |
| Timeline |
| Dynavax Technologies |
| Brainstorm Cell Ther |
Dynavax Technologies and Brainstorm Cell Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dynavax Technologies and Brainstorm Cell
The main advantage of trading using opposite Dynavax Technologies and Brainstorm Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dynavax Technologies position performs unexpectedly, Brainstorm Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brainstorm Cell will offset losses from the drop in Brainstorm Cell's long position.| Dynavax Technologies vs. Candel Therapeutics | Dynavax Technologies vs. Cingulate Warrants | Dynavax Technologies vs. Unicycive Therapeutics | Dynavax Technologies vs. Cardio Diagnostics Holdings |
| Brainstorm Cell vs. Protalix Biotherapeutics | Brainstorm Cell vs. Corvus Pharmaceuticals | Brainstorm Cell vs. Aldeyra | Brainstorm Cell vs. Checkpoint Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |